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Ovarian clear cell carcinoma (CCC) is a histological type of epithelial ovarian cancer that is less responsive to
chemotherapy and associated with a poorer prognosis than serous and endometrioid carcinoma. Non-thermal
atmospheric pressure plasma which produces reactive species has recently led to an explosion of research in
plasma medicine. Plasma treatment can be applied to cancer treatment to induce apoptosis and tumor growth
arrest. Furthermore, recent studies have shown that a medium exposed to plasma also has an anti-proliferative
effect against cancer in the absence of direct exposure to plasma. In this study, we confirmed whether this indirect
plasma has an anti-tumor effect against CCC, and investigated whether this efficacy is selective for cancer cells.
Non-thermal atmospheric pressure plasma induced apoptosis in CCC cells, while human peritoneal mesothelial cells
remained viable. Non-thermal atmospheric pressure plasma exhibits selective cytotoxicity against CCC cells which
are resistant to chemotherapy.
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Epithelial ovarian carcinoma (EOC) is the most frequent
cause of gynecological cancer-related death in women in
Western countries. Ovarian clear-cell carcinoma (CCC),
a subtype of EOC, is relatively less sensitive to chemo-
therapy, and is therefore recognized as refractory ovar-
ian cancer (Kajiyama et al. 2012). Even though a
combination of carboplatin and paclitaxel have been
established as standard therapy for ovarian cancer
(McGuire et al. 1996), CCC shows lower response rates
(Itamochi et al. 2008; Anglesio et al. 2011), while serous
adenocarcinoma and endometrioid adenocarcinoma re-
spond well to this regimen. Moreover, the incidence of
CCC has been increasing, and it is now estimated to be
more than 20% in Japan, whereas that in Europe is re-
portedly 5-6% (Anglesio et al. 2011). Although various
additional molecular-targeting therapies, including anti-
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in any medium, provided the original work is pbeen investigated in order to overcome such chemore-
sistance, the effect of such treatment is not satisfactory,
and no treatment has been established for this histo-
logical subtype of EOC.
Plasma is defined as ionized gas containing energy par-
ticles including electrons, ions, neutral atoms, and mole-
cules such as free radicals and electronically excited
atoms. Since it has become possible to generate plasma
at room temperature and atmospheric pressure due to
the technical developments, plasma has been gaining
interest in medical field as well as industrial fields. In
medical field plasma has been studied and applied for
sterilization (Klampfl et al. 2012), implants (Coelho
et al. 2012), blood coagulation (Bergler et al. 2001),
and wound healing (Isbary et al. 2012). Additionally, it had
been demonstrated that plasma can induce apoptosis in
cancerous cells (Fridman et al. 2007; Keidar et al. 2011;
Kim et al. 2010a; Kalghatgi et al. 2011), and it is ex-
pected to provide an alternative for cancer treatment.
What is required for anti-neoplastic agents is to have se-
lective cytotoxicity against cancer cells with minimized
side effects on normal cells and have appropriate drugan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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geted tumor. Some researchers have reported the thera-
peutic potential of the selective cytotoxicity of plasma
(Keidar et al. 2011; Kim et al. 2009; Tanaka et al. 2011). In
our previous study, we also confirmed the selectivity of
plasma against EOC (Iseki et al. 2012; Utsumi et al. 2013).
Although the mechanism behind this selective cyto-
toxicity of plasma is not fully understood, plasma may
generate various reactive oxygen species (ROS), such as
superoxide (O2
▪-) hydroxyl (OH▪), hydrogen peroxide
(H2O2), singlet oxygen (
1O2-), ozone (O3), leading to per-
oxidation of the lipid double membrane and resulting in
apoptosis (Kalghatgi et al. 2011; Vandamme et al. 2012;
Ishaq et al. 2014; Yan et al. 2012a). Cancer cells generate
more intrinsic ROS than normal cells due to their high
metabolic activity. Therefore, cancer cells may be more
vulnerable to ROS-inducing reagents, like some chemo-
therapeutic drugs. Furthermore, several ROS generated by
plasma have also been detected in the culture medium
during exposure to plasma, called indirect plasma or
plasma-activated medium, and this has been applied to
cancer treatment. This method, in which cells are exposed
to some liquid exposed to plasma beforehand, has been
demonstrated to exhibit an anti-tumor effect comparable to
direct plasma (Kalghatgi et al. 2011; Tanaka et al. 2011;
Ryu et al. 2013). Considering the well-known charac-
teristic of EOC disseminating throughout the peritoneal
cavity, indirect plasma is suitable for intraperitoneal
administration.
In this study, using indirect plasma in the form of
nonequilibrium atmospheric pressure plasma (NEAPP),
which is a type of non-thermal atmospheric pressure
plasma, we demonstrated selective cytotoxicity against
CCC cells, which are less sensitive to chemotherapy
compared to normal cells. Taking intraperitoneal ad-
ministration into account, we used human omental
peritoneal mesothelial cells as normal cells.Results
Effect of NEAPP-AM on clear cell carcinoma cell line
We first evaluated the anti-tumor effect of NEAPP-AM
on the growth of the CCC cell line using the cell viability
assay. Figure 1 shows the cell viability of TOV21G cells
exposed to NEAPP-AM for 24 hrs, which was prepared
beforehand by exposure to NEAPP for the indicated
time. The viability decreased by approximately 61% when
cells were treated with NEAPP-AM-5, and 87% after being
treated with NEAPP-AM-8 compared to non-NEAPP-
exposed medium treatment (P <0.01). These findings sug-
gest that the NEAPP-AM treatment also has an anti-tumor
effect on CCC cells. Furthermore, we confirmed the anti-
tumor effect of NEAPP-AM on other EOC cell lines (ES-2,
SKOV3, and NOS2). Figure 2 shows the cell viabilities ofthese cells exposed to NEAPP-AM-8 for 24 hrs. Significant
cytotoxicity was demonstrated in every EOC cell line.
Morphological changes observed in EOC cell lines
induced by NEAPP-AM
Morphological investigations of EOC cells exposed to
NEAPP-AM were performed. Images of untreated EOC
cells are shown in (Figure 3A). The cells treated with
NEAPP-AM (15) -5 were observed 6 hrs after treatment
and displayed changes, such as shrinking, rounding up,
and detachment from dishes which were typical of apop-
tosis (Figure 3B).
Role of ROS and attenuated and enhanced NEAPP-AM
effect with NAC and BSO
Subsequently, we examined whether ROS produced by
NEAPP are responsible for the anti-tumor effects on CCC
cells as well as serous EOC cells in tests we previously per-
formed. To investigate the role of ROS in NEAPP-AM
treatment, TOV21G cells were pre-incubated with
NAC or BSO, followed by the addition of NEAPP-AM
for the indicated exposure times. The viability of
TOV21G cells was assayed 24 hrs after NEAPP-AM
treatment using the cell viability assay. As shown in
Figure 4, the growth-inhibitory effects of NEAPP-AM
were completely blocked on being pretreatment and
co-incubation with NAC (Figure 4A). In contrast, BSO
(Figure 4B) with NEAPP-AM decreased cell viability;
especially, BSO with NEAPP-AM-1, -3 led to a signifi-
cant decrease, compared to the control (NEAPP-AM
treatment alone) (P <0.01). These results suggest that
ROS in cells produced by NEAPP-AM play a critical
role in anti-tumor effects against EOC cells.
NEAPP-AM-induced apoptosis in TOV21G and SKOV3
Subsequently, we assessed whether the cytotoxic effect
of NEAPP-AM against TOV21G and SKOV3 was asso-
ciated with the induction of apoptosis by TUNEL assay.
To identify inner nucleosomal DNA strand breaks, a
characteristic feature of apoptosis, TUNEL staining was
performed at 4 hrs after NEAPP-AM, treatment, as
described in Materials and Methods. Compared with
control cells, both TOV21G and SKOV3 cells treated
with NEAPP-AM showed more TUNEL-positive staining
cells, indicating that NEAPP-AM induced apoptosis in
both cell lines (Figure 5).
Selective cytotoxic effect of NEAPP-AM on TOV21G cells
compared with OHFC and HPMC
We finally examined whether NEAPP-AM has a selective
anti-proliferative effect on cancer cells without causing ad-
verse reactions in normal cells. TOV21G, OHFC, and
HPMC cells were exposed to NEAPP-AM (25)-8 for 24 hrs
and investigated with cell viability assay. As shown in
Figure 2 Systematic analysis of the effect of NEAPP-AM on some EOC cell lines. ES-2, SKOV3 and NOS2 cells were treated with NEAPP-AM-8.
Cell viability was determined 24 hrs after treatment with the cell viability assay. Cell viability of treated cells was normalized to the control. *P < 0.05,
**P < 0.01 versus control.
Figure 1 The effect of NEAPP-AM on cell viability. Viability of TOV21G ovarian clear cell carcinoma cells treated with NEAPP-activated medium
(NEAPP-AM), as measured by the cell viability assay. TOV21G cells were plated in 96-well plates and incubated at 37°C with 5% CO2. After 24 hrs,
the culture medium was replaced with NEAPP-AM and the cells were incubated for another 24 hrs. The cell proliferation rate was evaluated
relative to the control with the cell viability assay. Each column represents the mean, and the bars show SD. Assays were performed in triplicate.
*P < 0.05, **P < 0.01 versus control.
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Figure 3 The morphological changes of EOC cells after NEAPP-AM treatment. A: Representative images of untreated EOC cells (TOV21G,
ES-2, SKOV3, and NOS2). B: EOC cells (TOV21G, ES-2, SKOV3, and NOS2) treated with NEAPP-AM for 6 hrs.
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after being treated with NEAPP-AM were 29, 100, and
71%, respectively [OHFC vs. TOV21G (P <0.01): HPMC
vs. TOV21G (P < 0.01). Remarkably, the cytotoxic ef-
fects of NEAPP-AM on normal human peritoneal cells
are less sensitive than on cancer cells.
Discussion
Plasma has been used for a long time for industrial pur-
poses. Recently, with the rapid advancement of devices
that can generate plasma at atmospheric pressure,
plasma has received much attention in medical fields.Many researchers have demonstrated plasma-induced
apoptosis in cancer cells (Fridman et al. 2007; Yan et al.
2012b; Kim et al. 2010b), and some of them have applied
this treatment to in vivo studies (Keidar et al. 2011;
Vandamme et al. 2012; Vandamme et al. 2010). Al-
though these studies have indicated plasma treatment
also has anti-tumor effects in vivo, the application is
often limited to skin cancer or a xenografted model be-
cause of the characteristics of the device. When direct
plasma was applied to an intraperitoneal tumor, the treat-
ment became very invasive, involving an abdominal oper-
ation (Brulle et al. 2012). So, we have been focusing on
Figure 4 Role of ROS and attenuated and enhanced NEAPP-AM sensitivity with NAC and BSO. A, B: Influence of intracellular ROS
modulation by NAC and BSO on NEAPP-AM-induced cell death. A: TOV21G cells were pretreated with NAC (4 mM) (A) or BSO (2 mM) (B) for
1 hr and then exposed to NEAPP-AM with NAC or BSO for an additional 24 hrs. The cell viability assay was used for evaluation. Each column
represents the mean and the bars are SD. Data are representative of at least three independent experiments. *P < 0.05, **P < 0.01 versus control
without NAC treatment.
Figure 5 TUNEL assay. The TUNEL assay was performed to detect apoptosis in TOV21G and SKOV3 cells induced by NEAPP-AM. TOV21G and
SKOV3 cells were treated with NEAPP-AM or control medium. Cells were incubated for 4 hrs, then fixed, and the TUNEL assay was performed.
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Figure 6 Selective cytotoxic effect of NEAPP-AM on TOV21G cells compared with OHFC and HPMC. Cell viability of TOV21G, OHFC, and
HPMC after being treated with NEAPP-AM-8 was measured by the cell viability assay. Cells were seeded in collagen-coated 96-well plates and
incubated for 24 hrs, the culture medium was replaced with NEAPP-AM, and the cells were incubated for another 24 hrs. The cell proliferation
rate was evaluated relative to the control with the cell viability assay. *P < 0.05, **P < 0.01 versus TOV21G treated with NEAPP-AM-8.
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to administer plasma for ovarian cancer as safely as pos-
sible. ROS or reactive nitrogen species generated by
plasma have been shown to be transferred to the medium
and exert anti-tumor effect comparable to direct plasma
(Kalghatgi et al. 2011; Yan et al. 2012a; Ryu et al. 2013).
We recently reported the anti-proliferative effects of
NEAPP-AM against chemoresistant EOC cell lines de-
rived from serous EOC cells in vitro and in vivo in a xeno-
grafted model (Utsumi et al. 2013). In this study, we used
a CCC cell line which is naturally chemoresistant and often
associated with a poor prognosis. Our experiments demon-
strated a selective cytotoxic effect of NEAPP-AM on CCC,
compared with normal human cells. Furthermore, the ma-
jority of patients with EOC have advanced intraperitoneal
metastasis and dissemination at the time of diagnosis.
Since it is important to target these disseminations with-
out damaging surrounding normal cells, we selected peri-
toneal mesothelial and fibroblastic cells as normal cells.
Several mechanisms involved in drug resistance of CCC
have been proposed, including decreased drug accumu-
lation, increased drug detoxification, and increased DNA
repair activity. However, the details underlying CCC’s resist-
ance to chemotherapy have not been clarified. Itamochiet al. suggested that the lower tumor proliferation may con-
tribute to its resistance to chemotherapy (Itamochi et al.
2008). Genetically, glutathione peroxidase (GPx3), glutare-
doxin (GLRX), and superoxide dismutase (SOD2) were
highly expressed in CCC tumors, and high levels of these
antioxidant proteins may be associated, in part, with the
chemoresistant phenotype of CCC (Schwartz et al. 2002).
On the other hand, the anti-tumor effect of plasma has
been suggested to be triggered through lipid peroxidation
with an excessive amount of ROS generated by plasma.
Apoptosis caused by lipid peroxidation has been related to
the activity of p53, which is known as a tumor suppres-
sor triggering cell-cycle arrest and apoptosis (Yan et al.
2012a; Tsuzuki et al. 2007). Xu Yan et al. examined
mRNA expression, and revealed that cyclin B1 and Cdc2
are decreased at the transcriptional level after plasma
treatment, while the expression of p21 Cdk inhibitor, as
well as that of tumor suppressor p53, is enhanced (Yan
et al. 2012b). This mechanical difference between chemo-
therapy and plasma treatment may contribute to the anti-
proliferative effect of plasma against CCC.
Although, plasma may be successfully used for superficial
lesions, including the stimulation of wound healing,
sterilization of medical instruments, and removal of
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pheric pressure plasma as a treatment for cancer patients,
there may be some limitations such as a lack of the infil-
trating capability of plasma. The depth that can be pene-
trated by plasma is thought to be limited. We are trying to
apply NEAPP-AM treatment to intraperitoneal micro dis-
semination which is difficult to control with conventional
treatments.
Conclusion
In conclusion our results suggest that NEAPP-AM can in-
duce apoptosis in CCC while normal cells are less damaged.
These findings indicate the possibility of being able to apply
this technical modality intraperitoneally, and we are now
trying to apply NEAPP-AM to I.P. therapy on a murine
peritoneal metastasis model with EOCs including chemo-
resistant cells. NEAPP-AM may be a promising new alter-
native for chemoresistant EOC treatment.
Methods
Cell culture
We used four ovarian cancer cell lines involving omentum-
derived human fibroblastic cells (OHFC) and human peri-
toneal mesothelial cells (HPMC). TOV21G, ES-2, and
SKOV3 were purchased from the American Tissue Culture
Collection. The NOS2 cells, derived from serous EOC,
were established in our institute. We described the details
in our previous reports (Kajiyama et al. 2007a). OHFC and
HPMC were isolated from pieces of human omentum. The
tissues were obtained from consenting patients undergoing
abdominal surgery at our institute (Kajiyama et al. 2007b).
The study was approved by the institutional ethics commit-
tee (Approval number: 1234, Ethics Committee of Nagoya
University). All cell lines were maintained in RPMI-1640
(Sigma, St. Louis, MO, USA) supplemented with 10% fetal
bovine serum (FBS) and penicillin-streptomycin at 37°C in
a humidified atmosphere of 5% CO2.
Experimental system specification and production of
nonequilibrium atmospheric pressure plasma-activated
medium (NEAPP-AM)
The details of this experimental NEAPP system were pre-
viously described (Iseki et al. 2012). Discharge conditionsFigure 7 Scheme of procedure to produce nonequilibrium atmosphewere in argon gas (2 standard liters/ min; slm) excited by
applying 10 kV of a 60-Hz commercial power supply to
two electrodes with a distance of 8 mm. In brief, NEAPP
with an ultra-high electron density (approximately 2 ×
1016 cm-3) was provided with an ultra-high O density esti-
mated at around 4 × 1015 cm-3 (Iseki et al. 2012). Further-
more, the generation of ROS, such as hydroxyl radicals,
singlet oxygen radicals, nitrogen oxide, and nitrogen, was
confirmed by optical emission spectroscopy. We exposed
the above NEAPP to RPMI-1640 without FBS separately
from the cells, which is designated as ‘nonequilibrium at-
mospheric pressure plasma-activated medium (NEAPP-
AM)’. A schema of this procedure is shown in Figure 7.
The separated distance between the plasma source and
medium (L) is critical to reproduce consistent data, so
all experiments were performed under two set condi-
tions: L = 15 and 25 mm, indicated as NEAPP-AM (15)
and NEAPP-AM (25), respectively. The cytotoxic effect
of NEAPP-AM (15) was suggested to be stronger than
NEAPP-AM (25). NEAPP-AM (25) was used for cell
viability assays, while NEAPP-AM (15) was used for cell
imaging assays. The duration of plasma treatment ranged
from 0 to 8 minutes. Six milliliters of RPMI-1640 medium
was placed in a 60-mm dish. The center of each 60-mm
dish was treated several times (1, 3, 5, and 8 min) with
NEAPP fixed above the dish at a single point, referred to
as NEAPP-AM-1, -3, -5, and -8, respectively. NEAPP ex-
posure can cause changes to media in pH or temperature.
We have referred to them in our previous manuscript and
they were almost negligible (Iseki et al. 2012). ROS in
medium were generated homogeneously due to the con-
vective flow by gas or sufficient immixture before the
addition to cells.
Cell viability assay
The effect of NEAPP-AM on the viability of cells was
measured with the Aqueous One Solution Cell Prolifera-
tion Assay kit (Promega, Madison, WI, USA), according
to the manufacturer’s instructions. Absorbance was then
measured at 490 nm with a microplate absorbance
reader (ELx808; Bio Tek, U.S.A.). The cells were plated
in 96-well plates at a density of 1 × 104 cells per well in
100 μL of complete culture medium. When the assayric pressure plasma-activated medium.
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used for all cell lines. The next day, cells were treated
with NEAPP-AM (25) (1-8 min/6 mL) for 24 hrs. Exper-
iments were performed in triplicate.The influence of modulation of reactive oxidative species
(ROS) by N-acetyl cysteine and L-buthionine-[S, R]-sulfoximine
N-acetyl cysteine (NAC, Sigma-Ardrich, St. Louis, MO,
USA), known as an intracellular ROS scavenger, was
used to attenuate the effect of ROS. Alternatively,
L-buthionine-[S, R]-sulfoximine (BSO, Sigma-Aldrich,
St. Louis, MO, USA) , an inhibitor of GSH synthesis,
was used to enhance the effect of ROS. It is known that
GSH is one of the most abundant and effective compo-
nents of the defense system against free radicals, in-
cluding ROS (Jefferies et al. 2003). The compounds
NAC and BSO were added to cells at a final concentra-
tion of 4 and 2 mM, respectively. The required volume
of each drug was added directly to complete the cell cul-
ture medium 1 hrs before NEAPP-AM treatment and
NEAPP-AM to achieve the desired final concentrations,
respectively. Cell viability was examined with the “cell via-
bility assay”.TUNEL assay
Apoptotic cells were identified using the In Situ Cell Death
Detection Kit, Fluorescein (Roche Applied Science,
Mannheim, Germany), according to the manufacturer’s
instructions. TOV21G and SKOV3 cells (2 × 104/well)
were seeded in a collagen-coated 8-well cover glass, in-
cubated for 24 hrs, and then treated with NEAPP-AM
(15)-5 or serum-free medium as a control. After 4 hrs of
incubation, cells were fixed with 4% paraformaldehyde
and the TUNEL reaction mixture was added. After be-
ing incubated in a chamber for 60 min at 37°C, cells
were observed with a fluorescence microscope. This ex-
periment was repeated at least three times.Statistical analysis
Data are presented as means ± SD from at least three in-
dependent experiments. Statistical analysis of the data
between two gropes was performed using Student’s t-test
and statistical analysis between more than two gropes
was performed by Dunnett’s test or Tukey-Kramer test
Differences between groups were considered significant
at P < 0.05.
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